A piece of news
During the sessions, participants were given an overview of both ecosystems by local experts. The Virtual Disruptour program by Biocat and ACCIÓ is now in its second edition
Nine companies from the BioRegion have participated digitally in a virtual immersion in Silicon Valley and New York's healthcare and entrepreneurship ecosystem. The initiative, organized by Biocat and ACCIÓ (Silicon Valley and New York office) under the name Virtual Disruptour, has allowed participating companies and projects to meet and interact with investors, companies and pioneering academic stakeholders in the US healthcare sector. The startups participating in this second edition were ADmit Therapeutics SL, Aniling, Aromics, Doctomatic, Glycardial Diagnostics, MiMARK Diagnostics, Mangrana Ventures, Singularity Biomed i The Blue Box Biomedical Solutions.
During the sessions, participants got an overview of the two ecosystems and local experts explained how innovation takes place in their companies and what requirements are necessary to be able to develop a project in a more successful way. Some of the recommendations they shared are: